Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-blind, Multi-center Study to Evaluate the Safety and Efficacy of Oral Sodium Fusidate (CEM-102) Compared to Oral Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infections

NCT02570490 is registered in ClinicalTrials.gov with Arrevus Inc. as lead sponsor.

NCT NCT02570490
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02570490 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-blind, Multi-center Study to Evaluate the Safety and Efficacy of Oral Sodium Fusidate (CEM-102) Compared to Oral Linezolid in the Treatment of Acute Bacterial Skin and Skin Structure Infections
Lead sponsor
Arrevus Inc.
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2015
Completion date
November 30, 2016
Enrollment
716 (actual)
Sites
62

Conditions

As the registry lists them; a condition with its own page is linked.

acute bacterial skin and skin structure infections